Genascence Corporation today announced that Thomas Chalberg , Ph.D., founder and chief executive officer, will present a corporate update at the Biotech Showcase 2024 being held January 8-10, 2024 in San Francisco, CA.
PALO ALTO, Calif., Dec. 20, 2023 /PRNewswire/ -- Genascence Corporation (“Genascence”), a clinical-stage biotechnology company revolutionizing the treatment of prevalent musculoskeletal diseases with gene therapy, today announced that Thomas Chalberg, Ph.D., founder and chief executive officer, will present a corporate update at the Biotech Showcase 2024 being held January 8-10, 2024 in San Francisco, CA. Details of Genascence’s corporate update presentation are as follows: Date/Time: Monday, January 8, 2024 at 4:30 PM PT About Genascence Corporation
SOURCE Genascence |